Weight

Tirzepatide

Dual-action GLP-1 / GIP that acts on two metabolic pathways.

Who it’s for

Adults for whom a doctor judges a dual-pathway medication the better fit, under close doctor guidance.

How it works

By engaging both GLP-1 and GIP receptors it curbs appetite and improves how your body handles glucose and fat. Dosing is stepped up slowly.

What to expect

Gradual weight and metabolic changes over months, with the same emphasis on monitoring and sustainable habits.

What it costs

We make our money on the membership. Not on your medication.

Membership

Price announced before launch

Medication

Cost plus a markup confirmed at launch

Dispensed by a US-licensed pharmacy. Compounded medications are not FDA-approved.

Ordered, or bring your own

Panels

Confirmed at launch

Baseline before you start, then monitoring on your treatment's schedule. Paid separately from the membership and priced to your tests; you see the cost before you book.

Find out whether you actually need this.

Enrollment is not open yet, so this starts with the waitlist.

Join the waitlist

This page is illustrative and pre-launch. Tirzepatide is described in general terms; eligibility, dosing and outcomes are determined by a licensed doctor based on your evaluation.